G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 26.4 SEK 32% Market Closed
Market Cap: 1.7B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genovis AB
Operating Income Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Operating Income
kr23.2m
CAGR 3-Years
41%
CAGR 5-Years
31%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Operating Income
kr805m
CAGR 3-Years
5%
CAGR 5-Years
36%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Operating Income
-kr100m
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Operating Income
kr351m
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
23%
MedCap AB (publ)
STO:MCAP
Operating Income
kr282m
CAGR 3-Years
41%
CAGR 5-Years
32%
CAGR 10-Years
26%
M
Magle Chemoswed Holding AB
STO:MAGLE
Operating Income
kr21.7m
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Genovis AB's Operating Income?
Operating Income
23.2m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Operating Income amounts to 23.2m SEK.

What is Genovis AB's Operating Income growth rate?
Operating Income CAGR 5Y
31%

Over the last year, the Operating Income growth was -51%. The average annual Operating Income growth rates for Genovis AB have been 41% over the past three years , 31% over the past five years .

Back to Top